Payments to Acquire Property, Plant, and Equipment of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Intra-Cellular Therapies, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $0, a 100% decline year-over-year.
  • Intra-Cellular Therapies, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $322,000, a 20% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $269,000, a 65% decline from 2022.
  • Intra-Cellular Therapies, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $778,000, a 139% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $322,000 +$53,000 +20% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $269,000 -$509,000 -65% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $778,000 +$453,000 +139% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $325,000 +$58,000 +22% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $267,000 -$433,395 -62% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $700,395 +$309,127 +79% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $391,268 -$332,161 -46% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $723,429 +$674,465 +1377% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $48,964 -$811,631 -94% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $860,595 +$848,833 +7217% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $11,762 -$21,493 -65% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $33,255 -$5,702 -15% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $38,957 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY

Intra-Cellular Therapies, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $0 -$566,000 -100% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q1 2022 $566,000 +$566,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $0 -$22,049 -100% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $22,049 -$45,144 -67% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $67,193 -$227,899 -77% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $295,092 +$266,594 +935% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $28,498 +$24,624 +636% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $3,874 -$516,522 -99% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $520,396 +$517,276 +16579% 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2016 2016 Q1
Q1 2014 $3,120 -$1,935 -38% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q1 2013 $5,055 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.